Search research articles
Contact Us
Filters
Showing results (421-430 of 478) with videos related to
Page
of 48
Sort By:
Frontiers in Oncology
|
April 3, 2023
Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma
Zhe-Rong Zheng, Hsiu-Ying Ku, Kun-Chieh Chen, et al.
Journal of the Chinese Medical Association : JCMA
|
January 22, 2024
The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty
Kuo-Ming Yang, Mei-Tzu Wang, Chi-Wei Tao, et al.
The Oncologist
|
January 16, 2024
Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy
Hsing-Wu Chen, Yao-Wen Kuo, Chung-Yu Chen, et al.
Journal of Cancer
|
May 29, 2018
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
Shu-Yung Lin, Ching-Yao Yang, Bin-Chi Liao, et al.
Shock (Augusta, Ga.)
|
February 19, 2015
Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis
Kuei-Pin Chung, Hou-Tai Chang, Shyh-Chyi Lo, et al.
Human Vaccines & Immunotherapeutics
|
February 19, 2021
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials
Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges
Laura Q M Chow, Fabrice Barlesi, Erin M Bertino, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 19, 2017
Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter retrospective SEQUENCE study
Gee-Chen Chang, Chien-Hua Tseng, Kuo-Hsuan Hsu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2019
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
Ching-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean, Cameron Brennan, Jin-Yuan Shih, et al.
Page
of 48
Search research articles
Search
Showing results (421-430 of 478) with videos related to
Sort By:
Page
of 48
Frontiers in Oncology
|
April 3, 2023
Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma
Zhe-Rong Zheng, Hsiu-Ying Ku, Kun-Chieh Chen, et al.
Journal of the Chinese Medical Association : JCMA
|
January 22, 2024
The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty
Kuo-Ming Yang, Mei-Tzu Wang, Chi-Wei Tao, et al.
The Oncologist
|
January 16, 2024
Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy
Hsing-Wu Chen, Yao-Wen Kuo, Chung-Yu Chen, et al.
Journal of Cancer
|
May 29, 2018
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
Shu-Yung Lin, Ching-Yao Yang, Bin-Chi Liao, et al.
Shock (Augusta, Ga.)
|
February 19, 2015
Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis
Kuei-Pin Chung, Hou-Tai Chang, Shyh-Chyi Lo, et al.
Human Vaccines & Immunotherapeutics
|
February 19, 2021
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials
Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges
Laura Q M Chow, Fabrice Barlesi, Erin M Bertino, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 19, 2017
Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter retrospective SEQUENCE study
Gee-Chen Chang, Chien-Hua Tseng, Kuo-Hsuan Hsu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2019
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
Ching-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean, Cameron Brennan, Jin-Yuan Shih, et al.
Page
of 48